Organised by Prof. Ludovic Vallier’s research group at the Berlin Institute of Health at Charité (BIH), with Dylan Liabeuf, Anastasiia Maksiuk, Daniella Fradin and Katja Püstow leading the organisation, the second Berlin Organoid Symposium brought together over 220 international scientists at Bayer…
In July 2026, Dr. Benjamin Wild took over as head of the new research group “AI in Healthcare and Life Sciences” at the Berlin Institute of Health at Charité (BIH). He has been conducting research since 2021 at the Center of Digital Health at the Berlin Institute of Health at Charité (BIH), which is…
A research team led by Prof. Dr. Kirsten Kübler at the Berlin Institute of Health at Charité (BIH) has received the Rhonda’s Award 2027 from the Mucinous Ovarian Cancer Coalition, worth $100,000, for its project investigating the origins of mucinous ovarian cancer. The researchers are studying which…
How equitable is our healthcare system, and what role does gender play in this context? Founded in 2021, the Round Table of Women in Healthcare brings together the voices of eleven organizations, including the Berlin Institute of Health at Charité (BIH). Together, they aim to increase the number of…
The Co-Innovation Programme with Enterprise Singapore, coordinated by the Charité BIH ARC Innovation Center (CBAIC), brings together innovative companies with researchers and clinicians from Charité and BIH in the fields of health and biomedicine. Five start-ups from Singapore have successfully…
The Berlin Institute of Health at Charité (BIH) today launched a groundbreaking analytical platform that combines high-resolution 3D light microscopy, molecular genomic and proteomic analysis, and AI-driven evaluation. Developed in partnership with Roche Diagnostics, RoX Health, ZEISS, Bruker…
Resilience Care, a leading player in multi-pathology remote monitoring, today announced
the acquisition of Recovery Cat, a Germany-based digital health company specializing in
psychiatric care. The company aims to accelerate its expansion across Europe to provide
personalized, continuous, and…
Prof. Dr. med. Nathanael Raschzok, Fellow of the BIH Charité Advanced Clinician Scientist Pilot Program, and his research group at the Department of Surgery have received funding from German Cancer Aid (Deutsche Krebshilfe) for the multicenter GTO-001 trial. It aims to give patients with…
How well a bone heals after a fracture depends not only on individual cell types. The immediate environment in which these cells communicate with one another also plays a crucial role. A new study by researchers at the Berlin Institute of Health at Charité (BIH) shows how immune cells and bone cells…
Human organ models offer new opportunities to better understand diseases and develop more targeted therapies. The COVID-19 pandemic provided a unique scientific test case: Within a remarkably short period of time, researchers used a wide range of cell, organoid and tissue models to study the same…
The Oncovirtuous team, led by Dr. Anja Geisler, Leslie Kamstra, and Esther Horn, has set itself the goal of increasing the therapeutic efficacy of oncolytic viruses (OVs) following intravenous administration, thereby developing the next generation of cancer immunotherapy for the treatment of…
Genome sequencing has revolutionized the diagnosis of rare diseases. For many patients, however, it is not sufficient on its own to reach a definitive diagnosis. In these cases, combining genomic data with protein values in the patients’ blood can provide more insight into rare diseases. This was…
This workshop aims to equip stem cell biologists with a comprehensive introduction to computational single-cell genomics, focusing on data analysis using software from the scverse ecosystem. Designed for both beginners and advanced users, the workshop will provide hands-on experience with key tools…
Tim Luetkens work focuses on the development of effective and safe cell- and antibody-based therapies for cancer and neurodegenerative diseases. Cellular immunotherapies have revolutionized the treatment of cancer and changed academic and industry research paradigms. His Cell Engineering Lab aims to…
A conference with little preparation needed: mainly focused on discussing your science and connecting with other PhD students. No hard deadlines, just bring your (recycled) poster and join us in talking about the exciting projects happening at BIH!
Early- and intermediate-career scientists are offered the opportunity to network with a distinguished researcher or a person active in the field of technology transfer. During this open, informal seminar, we will discuss topics such as career planning, reconciliation of work and family life, but…
This event, organized by Charité and BIH highlights trans identities, rights, and current developments. The program includes talks, discussion, and a workshop.
Join us to create and edit Wikipedia articles together with experienced members of the WomenEdit Group Berlin to make Wikipedia more diverse! No experience necessary.
Early- and intermediate-career scientists are offered the opportunity to network with a distinguished researcher or a person active in the field of technology transfer. During this open, informal seminar, we will discuss topics such as career planning, reconciliation of work and family life, but…
We bring together the relevant stakeholders in the field of gene & cell therapy research to discuss the latest developments in science and political and economic challenges.
The event will be in German:
Du arbeitest im Gesundheitswesen? Bist Studierende*r oder in Ausbildung? Dann sei dabei, wenn wir anlässlich des Tags der Menschenrechte ein starkes Zeichen setzen – für den gleichberechtigten Zugang zur Gesundheitsversorgung!
We are excited to invite you to the Trans* Day of Remembrance 2024: Honoring Lives with Courage!
View event
BIH Newsletter
You would like to receive the latest information from the Berlin Institute of Health (BIH)? Then subscribe to our newsletter and receive regular updates on our success stories in research and translation.
